IgA Nephropathy

Atacicept in Subjects With IgA Nephropathy

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

A Phase IIa Study in Primary IgA Nephropathy Patients

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

IgA Nephropathy Registration Initiative of High Quality (INSIGHT)

Correlation of Microbiome and Metabonomics With IgA Nephropathy

Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)

A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United States

Serum and Urinary sCD163 in IgA Nephropathy

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

TESTING -ON Post-Trial ObservatioNal Cohort Study

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Study of BHV-1400 in IgA Nephropathy

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy